ABSTRACT
The widespread use of combined antiretroviral therapies has greatly reduced morbidity and mortality in HIV-infected patients. Although the success of combination therapy has created hope for long-term treatment, the extensive use of these highly active antiretroviral therapies (HAART) has also uncovered previously uncharacterized adverse drug reactions.
